gefitinib has been researched along with butein in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (butein) | Trials (butein) | Recent Studies (post-2010) (butein) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 171 | 0 | 110 |
| Protein | Taxonomy | gefitinib (IC50) | butein (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 8 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.0046 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.73 | |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 7.3 | |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 6.4 | |
| Beta-secretase 1 | Homo sapiens (human) | 2.37 | |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode, AM; Chen, H; Dong, Z; Jeong, CH; Jung, SK; Kim, JE; Lee, HJ; Lee, KW; Lee, MH; Lee, SY; Lim, DY; Lim, TG | 1 |
1 other study(ies) available for gefitinib and butein
| Article | Year |
|---|---|
Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chalcones; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung; Lung Neoplasms; Mice, Nude; Molecular Docking Simulation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Quinazolines | 2015 |